Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Three Drug Regimens for Newly Diagnosed Multiple Myeloma Transplant-Ineligible Elderly Patients - a Systematic Review

Abdul Aziz Siddiqui, MD, Kazi Najamus-saqib Khan, Arafat Ali Farooqui, MD, Muhammad Saad Farooqi, MD, Muhammad Junaid Tariq, MD, Faiz Anwer, MD

Blood (2019) 134 (Supplement_1): 5574.

https://doi.org/10.1182/blood-2019-132095

Published: 2019

Journal Articles

Role of Echocardiography and Cardiac Biomarkers in Early Detection of Hematopoietic Stem Cell Transplantation Associated Cardiotoxicity

Ana Carolina Oliver, MD, Roberto Superchi, MD, Superchi Federico, MD, Canabal Matilde, MD, Jubin Silvana, Lic, Carolina Errecarte, MD, Caneiro Ada, MD, Silvia Pierri, MD, Sebastian Galeano, MD, Eloisa Riva, MD, Bello Laura, MD, Regis Gai, MD, Miller Andrew, MD, Pablo J. Muxi, MD, Ricardo Fabian Mosquera, MD

Blood (2019) 134 (Supplement_1): 5688.

https://doi.org/10.1182/blood-2019-127680

Published: 2019

Journal Articles

Cardiac Injury and Microvascular Ischemia in Sickle Cell Disease

Kiranveer Kaur, Ying Huang, MS, MA, Subha Raman, MD MS, Eric H. Kraut, MD, Payal Desai, MD

Blood (2019) 134 (Supplement_1): 2286.

https://doi.org/10.1182/blood-2019-125445

Published: 2019

Journal Articles

An Assessment of Race As a Risk Factor for Doxorubicin-Related Cardiotoxicity in Diffuse Large B Cell Lymphoma

Ahmed Toure, BA, Yiyuan Wu, MS, Paul J Christos, Dr.P.H., M.S., Peter Martin, FRCPC, MD MS

Blood (2019) 134 (Supplement_1): 2205.

https://doi.org/10.1182/blood-2019-131567

Published: 2019

Journal Articles

Carfilzomib Induces Acute Endothelial Dysfunction Which Correlates with the Occurrence of Cardiovascular Events

Efstathios Kastritis, MD, Aggeliki Laina, MD, Maria Gavriatopoulou, MD, Georgios Georgiopoulos, MD, Evangelos Eleutherakis-Papaiakovou, MD, Fotiou Despina, MD, Nikolaos Kanellias, MD, Ioanna Dialoupi, MD, Nikolaos Makris, Efstathios Manios, MD, Magdalini Migkou, MD, Dimitrios C. Ziogas, MD, Maria Roussou, MD, Aristea-Maria Papanota, MD, Eleni-Dimitra Papanagnou, Evangelos Terpos, MD PhD, Ioannis P. Trougakos, Kimon Stamatelopoulos, MD, Meletios A Dimopoulos, MD

Blood (2018) 132 (Supplement 1): 3247.

https://doi.org/10.1182/blood-2018-99-113792

Published: 2018

Journal Articles

Genotypic Groups As Risk Factor for Cardiac MR Abnormalities and Complications in Thalassemia Major

Alessia Pepe, MD, Antonella Meloni, PhD, Stefano Salvadori, Silvia Macchi, MD, Angelantonio Vitucci, Mauro Murgia, MD, Aurelio Maggio, MD, Maria Flavia Fiorenza, Francesco Massei, Francesca Valeria Commendatore, Pietro Giuliano, Vincenzo Positano, Laura Pistoia

Blood (2018) 132 (Supplement 1): 1057.

https://doi.org/10.1182/blood-2018-99-112795

Published: 2018

Journal Articles

Incidence and Predictors of Left Ventricular Dysfunction Among Acute Myeloid Leukemia Patients

Zakaria Almuwaqqat, MD, Manila Gaddh, MD, Danielle Schlafer, Pharm D, BCOP, Don Hutcherson, RPh, Martha L. Arellano, MD, Susmita Parashar, MD MPH, MS, Vamsi Kota, MBBS

Blood (2017) 130 (Supplement 1): 5025.

https://doi.org/10.1182/blood.V130.Suppl_1.5025.5025

Published: 2017

Journal Articles

Traceable Red Cell Distribution Width Modifications Are Observed Prior to MDS Diagnosis and Primarily Associated with Cardiovascular Organ Dysfunction

Claudia Rodriguez, MD,, Alcedo Pedro, Sarvari Venkata Yellapragada, MD, Martha P. Mims, MD PhD, Gustavo A. Rivero, MD

Blood (2016) 128 (22): 5537.

https://doi.org/10.1182/blood.V128.22.5537.5537

Published: 2016

Journal Articles

Ruxolitinib Used to Treat Hypereosinophilic Syndrome

Seung Lee, bs, Coby Palmares, Niko Koutsoukos, J. Brice Weinberg, MD, Trisa Palmares, MD, Alice Song, MD, Harold Song, MD, Sheila Benedicto, bs, Michael Song, bs, Vu Phan, MD, Julia Song, MD

Blood (2016) 128 (22): 5500.

https://doi.org/10.1182/blood.V128.22.5500.5500

Published: 2016

Journal Articles

Selective MEK Inhibition with AZD-6244 (selumetinib) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A University of Chicago Phase II Consortium Trial

Natalie Galanina, MD, Sonali M. Smith, MD, Chuanhong Liao, PhD, Adam M. Petrich, MD, Bernadette Libao, Ron Gartenhaus, MD, Jason R Westin, MD, Kenneth S. Cohen, MD, James Knost, MD, Walter Stadler, MD, Austin Doyle, MD, Theodore Karrison, PhD, Leo I. Gordon, MD, Andrew M Evens, DO, MS

Blood (2015) 126 (23): 3990.

https://doi.org/10.1182/blood.V126.23.3990.3990

Published: 2015

Journal Articles

Vorinostat in Combination with Lenalidomide (L) and Dexamethasone (d) in Multiple Myeloma Patients Refractory to Previous Lenalidomide-Containing Regimens: Results of a Phase IIb Trial

Larysa Sanchez, MD, Yucai Wang, MD PhD, Laura McBride, RN, BSN, OCN, CCRP, Elizabeth Bilotti, MSN, David H. Vesole, MD, Joshua Richter, MD, Noa Biran, MD, Palka Anand, Kristin Ivanovski, Ann McNeill, ANP, David Siegel, MD PhD

Blood (2015) 126 (23): 4264.

https://doi.org/10.1182/blood.V126.23.4264.4264

Published: 2015

Journal Articles

Serial Echocardiographic Assessment of Patients (Pts) with Relapsed Multiple Myeloma (RMM) Receiving Carfilzomib and Dexamethasone (Kd) Vs Bortezomib and Dexamethasone (Vd): A Substudy of the Phase 3 Endeavor Trial (NCT01568866)

Blood (2015) 126 (23): 4250.

https://doi.org/10.1182/blood.V126.23.4250.4250

Published: 2015

Journal Articles

Risk Factors for Cardiac Toxicities Associated with Proteasome Inhibitor Chemotherapy during Treatment of Multiple Myeloma

John H. Chen, Daniel J. Lenihan, MD, Sharon E. Phillips, MSPH, Madan H. Jagasia, Stacey A. Goodman, MD MS, Adetola A. Kassim, MD MS, Shelton L. Lacy, Kevin T. McDonagh, Javid J. Moslehi, MD, Tarsheen K. Sethi, MD MS, David A. Slosky, Oluchi C. Ukaegbu, MD, Robert F. Cornell

Blood (2015) 126 (23): 5363.

https://doi.org/10.1182/blood.V126.23.5363.5363

Published: 2015

Journal Articles

Left Ventricular Ejection Fraction Measurement and Doxorubicin-Based Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma

Deborah L Enns, PhD, David M Aboulafia, MD

Blood (2014) 124 (21): 1300.

https://doi.org/10.1182/blood.V124.21.1300.1300

Published: 2014

Journal Articles

Utility Of Routine Left Ventricular Ejection Fraction (LVEF) Measurement Prior To Administration Of Anthracycline-Based Chemotherapy In Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Deborah L Enns, PhD, David Aboulafia, MD

Blood (2013) 122 (21): 5599.

https://doi.org/10.1182/blood.V122.21.5599.5599

Published: 2013

Journal Articles

CMR Survey In a Large Cohort Of TI Patients

Antonella Meloni, PhD, Maria-Eliana Lai, MD, Stefania Vacquer, MD, Roberto Mattei, MD, Crocetta Argento, MD, Domenico Maddaloni, MD, Aurelio Maggio, MD, Cristina Salvatori, Gennaro Restaino, MD, Vincenzo Positano, MSc, Massimo Lombardi, MD, Alessia Pepe, MD, PhD

Blood (2013) 122 (21): 1015.

https://doi.org/10.1182/blood.V122.21.1015.1015

Published: 2013

Journal Articles

The Addition of Bevacizumab to Standard Therapy with R-CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Is Associated with an Increased Rate of Cardiac Adverse Events: Final Analysis of Safety and Efficacy Outcomes From the Placebo-Controlled Phase 3 MAIN Study

John F. Seymour, MBBS FRACP, Michael Pfreundshuh, MD, B. Coiffier, MD, Marek Trneny, MD, PhD, Laurie H. Sehn, MD, Eva Csinady

Blood (2012) 120 (21): 58.

https://doi.org/10.1182/blood.V120.21.58.58

Published: 2012

Journal Articles

Safety and Efficacy of Dasatinib Versus Imatinib by Baseline Cardiovascular Comorbidity In Patients with Chronic Myeloid Leukemia In Chronic Phase (CML-CP): Analysis of the DASISION Trial

Giuseppe Saglio, MD, PhD, Andreas Hochhaus, MD, Ph.D., Jorge E. Cortes, MD, Hagop Kantarjian, MD, Michele Baccarani, MD, M. Brigid Bradley-Garelik, MD, David Dejardin, Neil P. Shah, MD, Ph.D.

Blood (2010) 116 (21): 2286.

https://doi.org/10.1182/blood.V116.21.2286.2286

Published: 2010

Journal Articles

Pulmonary Hypertension Is Uncommon In Well-Transfused Thalassemia Major Patients

Jon Detterich, MD, Leila Noetzli, BS, Susan Carson, PNP, Paul Harmatz, MD, Thomas D. Coates, MD, John C Wood, MD, PhD

Blood (2010) 116 (21): 4273.

https://doi.org/10.1182/blood.V116.21.4273.4273

Published: 2010

Journal Articles

NT-Probnp as a Marker of Cardiopulmonary Compromise and Exercise Limitation In Adults with Sickle Cell Anemia In the Walk-PHaSST Study

Blood (2010) 116 (21): 1639.

https://doi.org/10.1182/blood.V116.21.1639.1639

Published: 2010

NARROW

Three Drug Regimens for Newly Diagnosed Multiple Myeloma Transplant-Ineligible Elderly Patients - a Systematic Review

Role of Echocardiography and Cardiac Biomarkers in Early Detection of Hematopoietic Stem Cell Transplantation Associated Cardiotoxicity

Cardiac Injury and Microvascular Ischemia in Sickle Cell Disease

An Assessment of Race As a Risk Factor for Doxorubicin-Related Cardiotoxicity in Diffuse Large B Cell Lymphoma

Carfilzomib Induces Acute Endothelial Dysfunction Which Correlates with the Occurrence of Cardiovascular Events

Genotypic Groups As Risk Factor for Cardiac MR Abnormalities and Complications in Thalassemia Major

Incidence and Predictors of Left Ventricular Dysfunction Among Acute Myeloid Leukemia Patients

Traceable Red Cell Distribution Width Modifications Are Observed Prior to MDS Diagnosis and Primarily Associated with Cardiovascular Organ Dysfunction

Ruxolitinib Used to Treat Hypereosinophilic Syndrome

Selective MEK Inhibition with AZD-6244 (selumetinib) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A University of Chicago Phase II Consortium Trial

Vorinostat in Combination with Lenalidomide (L) and Dexamethasone (d) in Multiple Myeloma Patients Refractory to Previous Lenalidomide-Containing Regimens: Results of a Phase IIb Trial

Serial Echocardiographic Assessment of Patients (Pts) with Relapsed Multiple Myeloma (RMM) Receiving Carfilzomib and Dexamethasone (Kd) Vs Bortezomib and Dexamethasone (Vd): A Substudy of the Phase 3 Endeavor Trial (NCT01568866)

Risk Factors for Cardiac Toxicities Associated with Proteasome Inhibitor Chemotherapy during Treatment of Multiple Myeloma

Left Ventricular Ejection Fraction Measurement and Doxorubicin-Based Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma

Utility Of Routine Left Ventricular Ejection Fraction (LVEF) Measurement Prior To Administration Of Anthracycline-Based Chemotherapy In Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

CMR Survey In a Large Cohort Of TI Patients

The Addition of Bevacizumab to Standard Therapy with R-CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Is Associated with an Increased Rate of Cardiac Adverse Events: Final Analysis of Safety and Efficacy Outcomes From the Placebo-Controlled Phase 3 MAIN Study

Safety and Efficacy of Dasatinib Versus Imatinib by Baseline Cardiovascular Comorbidity In Patients with Chronic Myeloid Leukemia In Chronic Phase (CML-CP): Analysis of the DASISION Trial

Pulmonary Hypertension Is Uncommon In Well-Transfused Thalassemia Major Patients

NT-Probnp as a Marker of Cardiopulmonary Compromise and Exercise Limitation In Adults with Sickle Cell Anemia In the Walk-PHaSST Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only